Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances

NCT03164135 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

GENETIC: CCR5 gene modification

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences

Collaborators

[object Object]
[object Object]